Study Reports. Licensor shall provide Company with (i) a quarterly progress study report within thirty (30) days after the end of each calendar quarter with respect to the performance of the Research Program, (ii) a comprehensive final study report for each study within [*] days after completion of such study, including the full data set and results of the applicable study, and (iii) a comprehensive final report for the Research Program within [*] days after the expiration or earlier termination of the Research Program.
Appears in 2 contracts
Sources: Exclusive License and Collaboration Agreement, Exclusive License and Collaboration Agreement (Audentes Therapeutics, Inc.)